Risk Evaluation and Mitigation Strategies for some Rx drugs

November 2010

You'll hear lots more about "REMS" as FDA phases in their new Risk Evaluation and Mitigation Strategies for some Rx drugs....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology whether dabigatran (Pradaxa) will replace warfarin for patients with atrial fibrillation
Gout lots of ads for new gout drugs...Uloric, Colcrys, and now Krystexxa
Asthma Spiriva (TIOtropium) used in some patients with asthma
Psychiatry New guidelines say to select antidepressants based on side effects, other medical conditions, drug interactions, and cost
Vaccines More adults are now candidates for pneumococcal vaccination
Gastroenterology whether sodium polystyrene sulfonate (Kayexalate, etc) is safe for hyperkalemia
Women's Health whether the new 10 mcg Vagifem (estradiol) vaginal tablet works as well as the 25 mcg strength
Pediatrics Up to 15% of babies and toddlers don't get enough iron
Obesity & Weight Loss what to do now that the weight loss drug Meridia (sibutramine) is gone
Substance Use Disorder People are abusing some unexpected OTC and Rx meds
Risk Evaluation and Mitigation Strategies for some Rx drugs